TAS6417 - CAS 1661854-97-2

TAS6417 (CAT: I019823) is a potent and selective oral inhibitor of the fibroblast growth factor receptor (FGFR) tyrosine kinases. By inhibiting FGFR signaling, TAS6417 blocks the activation of downstream signaling pathways involved in cell proliferation, survival, and angiogenesis. TAS6417 has shown promising efficacy in preclinical studies against various FGFR-driven solid tumors, including lung cancer, gastric cancer, and bladder cancer. It has demonstrated antitumor activity in both in vitro and in vivo models and is being investigated as a potential targeted therapy for FGFR-altered cancers. TAS6417 holds promise as a novel treatment option for patients with FGFR-driven malignancies.

Catalog Number: I019823

CAS Number: 1661854-97-2

Molecular Formula: C₂₃H₂₀N₆O

Molecular Weight:396.44

Purity: ≥95%

* For research use only. Not for human or veterinary use.


Property

Molecular Formula: C₂₃H₂₀N₆O
Molecular Weight396.44
Purity≥95%